Literature DB >> 33978236

Widespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides.

Vanesa Lafarga1, Oleksandra Sirozh1, Irene Díaz-López2, Antonio Galarreta1, Misaru Hisaoka3,4, Eduardo Zarzuela5, Jasminka Boskovic6, Bogdan Jovanovic3,4, Rafael Fernandez-Leiro7, Jaime Muñoz5, Georg Stoecklin3,4, Iván Ventoso2, Oscar Fernandez-Capetillo1,8.   

Abstract

Due to their capability to transport chemicals or proteins into target cells, cell-penetrating peptides (CPPs) are being developed as therapy delivery tools. However, and despite their interesting properties, arginine-rich CPPs often show toxicity for reasons that remain poorly understood. Using a (PR)n dipeptide repeat that has been linked to amyotrophic lateral sclerosis (ALS) as a model of an arginine-rich CPP, we here show that the presence of (PR)n leads to a generalized displacement of RNA- and DNA-binding proteins from chromatin and mRNA. Accordingly, any reaction involving nucleic acids, such as RNA transcription, translation, splicing and degradation, or DNA replication and repair, is impaired by the presence of the CPPs. Interestingly, the effects of (PR)n are fully mimicked by protamine, a small arginine-rich protein that displaces histones from chromatin during spermatogenesis. We propose that widespread coating of nucleic acids and consequent displacement of RNA- and DNA-binding factors from chromatin and mRNA accounts for the toxicity of arginine-rich CPPs, including those that have been recently associated with the onset of ALS.
© 2021 The Authors.

Entities:  

Keywords:  ALS; arginine-rich peptides; chromatin; mRNA; protamine

Mesh:

Substances:

Year:  2021        PMID: 33978236      PMCID: PMC8246256          DOI: 10.15252/embj.2019103311

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   14.012


  54 in total

1.  Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients.

Authors:  Shanye Yin; Rodrigo Lopez-Gonzalez; Ryan C Kunz; Jaya Gangopadhyay; Carl Borufka; Steven P Gygi; Fen-Biao Gao; Robin Reed
Journal:  Cell Rep       Date:  2017-06-13       Impact factor: 9.423

2.  Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS.

Authors:  Peter E A Ash; Kevin F Bieniek; Tania F Gendron; Thomas Caulfield; Wen-Lang Lin; Mariely Dejesus-Hernandez; Marka M van Blitterswijk; Karen Jansen-West; Joseph W Paul; Rosa Rademakers; Kevin B Boylan; Dennis W Dickson; Leonard Petrucelli
Journal:  Neuron       Date:  2013-02-12       Impact factor: 17.173

3.  Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS.

Authors:  Simona Rossi; Alessia Serrano; Valeria Gerbino; Alessandra Giorgi; Laura Di Francesco; Monica Nencini; Francesca Bozzo; Maria Eugenia Schininà; Claudia Bagni; Gianluca Cestra; Maria Teresa Carrì; Tilmann Achsel; Mauro Cozzolino
Journal:  J Cell Sci       Date:  2015-03-18       Impact factor: 5.285

4.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

5.  Toxic PR Poly-Dipeptides Encoded by the C9orf72 Repeat Expansion Target LC Domain Polymers.

Authors:  Yi Lin; Eiichiro Mori; Masato Kato; Siheng Xiang; Leeju Wu; Ilmin Kwon; Steven L McKnight
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

6.  Gene transfer mediated by polyarginine requires a formation of big carrier-complex of DNA aggregate.

Authors:  N Emi; S Kidoaki; K Yoshikawa; H Saito
Journal:  Biochem Biophys Res Commun       Date:  1997-02-13       Impact factor: 3.575

7.  Enhancement of the plaque-forming capacity of poliovirus ribonucleic acid with basic proteins.

Authors:  C E SMULL; E H LUDWIG
Journal:  J Bacteriol       Date:  1962-11       Impact factor: 3.490

Review 8.  The toxicology of heparin reversal with protamine: past, present and future.

Authors:  Emilia Sokolowska; Bartlomiej Kalaska; Joanna Miklosz; Andrzej Mogielnicki
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-06-06       Impact factor: 4.481

9.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

10.  C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles.

Authors:  Kyung-Ha Lee; Peipei Zhang; Hong Joo Kim; Diana M Mitrea; Mohona Sarkar; Brian D Freibaum; Jaclyn Cika; Maura Coughlin; James Messing; Amandine Molliex; Brian A Maxwell; Nam Chul Kim; Jamshid Temirov; Jennifer Moore; Regina-Maria Kolaitis; Timothy I Shaw; Bing Bai; Junmin Peng; Richard W Kriwacki; J Paul Taylor
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

View more
  6 in total

1.  A Streamlined Data Analysis Pipeline for the Identification of Sites of Citrullination.

Authors:  Aaron J Maurais; Ari J Salinger; Micaela Tobin; Scott A Shaffer; Eranthie Weerapana; Paul R Thompson
Journal:  Biochemistry       Date:  2021-09-07       Impact factor: 3.321

Review 2.  Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs.

Authors:  Izabela Rusiecka; Iwona Gągało; Ivan Kocić
Journal:  Tissue Barriers       Date:  2021-08-17

3.  Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM.

Authors:  Anna B Loveland; Egor Svidritskiy; Denis Susorov; Soojin Lee; Alexander Park; Sarah Zvornicanin; Gabriel Demo; Fen-Biao Gao; Andrei A Korostelev
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

4.  Widespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides.

Authors:  Vanesa Lafarga; Oleksandra Sirozh; Irene Díaz-López; Antonio Galarreta; Misaru Hisaoka; Eduardo Zarzuela; Jasminka Boskovic; Bogdan Jovanovic; Rafael Fernandez-Leiro; Jaime Muñoz; Georg Stoecklin; Iván Ventoso; Oscar Fernandez-Capetillo
Journal:  EMBO J       Date:  2021-05-12       Impact factor: 14.012

Review 5.  It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.

Authors:  Che-Pei Kung; Jason D Weber
Journal:  Front Cell Dev Biol       Date:  2022-01-26

6.  HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.

Authors:  Elke Braems; Valérie Bercier; Evelien Van Schoor; Kara Heeren; Jimmy Beckers; Laura Fumagalli; Lieselot Dedeene; Matthieu Moisse; Ilse Geudens; Nicole Hersmus; Arpan R Mehta; Bhuvaneish T Selvaraj; Siddharthan Chandran; Ritchie Ho; Dietmar R Thal; Philip Van Damme; Bart Swinnen; Ludo Van Den Bosch
Journal:  Acta Neuropathol       Date:  2022-07-27       Impact factor: 15.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.